Background: Galectin-3 (gal-3) is a β-galactoside-binding lectin associated tissue fibrosis and inflammation. There is limited understanding of the relationship between gal-3 and vascular health. Our aim was to assess the association between gal-3 and arterial stiffness in older adults. Methods: We conducted a cross-sectional study of 4275 participants (mean age of 75 years) from the Atherosclerosis Risk in Communities (ARIC) Study. Central arterial stiffness was measured by carotid-femoral pulse wave velocity (cfPWV). We evaluated the association of gal-3 with cfPWV using multivariable linear regression. Results: The median (interquartile range) gal-3 concentration was 16.5 (13.8, 19.8) ng/mL and mean cfPWV was 1163±303 cm/s. Higher gal-3 concentration was associated with greater central arterial stiffness after adjustment for age, sex, race-center, heart rate, systolic blood pressure, anti-hypertensive medication use, and current smoking status (β=36.4 cm/s change in cfPWV per log unit change in gal-3; 95% CI: 7.2, 65.5, p=0.015). The association was attenuated after adjusting for additional cardiovascular risk factors (β=17.3, 95% CI: -14.4, 49.0). Conclusions: In community-dwelling older adults, gal-3 concentration was associated with central arterial stiffness, likely sharing common pathways with traditional cardiovascular risk factors.
Background: Galectin-3 (gal-3) is a β-galactoside-binding lectin associated tissue fibrosis and inflammation. There is limited understanding of the relationship between gal-3 and vascular health. Our aim was to assess the association between gal-3 and arterial stiffness in older adults. Methods: We conducted a cross-sectional study of 4275 participants (mean age of 75 years) from the Atherosclerosis Risk in Communities (ARIC) Study. Central arterial stiffness was measured by carotid-femoral pulse wave velocity (cfPWV). We evaluated the association of gal-3 with cfPWV using multivariable linear regression. Results: The median (interquartile range) gal-3 concentration was 16.5 (13.8, 19.8) ng/mL and mean cfPWV was 1163±303 cm/s. Higher gal-3 concentration was associated with greater central arterial stiffness after adjustment for age, sex, race-center, heart rate, systolic blood pressure, anti-hypertensive medication use, and current smoking status (β=36.4 cm/s change in cfPWV per log unit change in gal-3; 95% CI: 7.2, 65.5, p=0.015). The association was attenuated after adjusting for additional cardiovascular risk factors (β=17.3, 95% CI: -14.4, 49.0). Conclusions: In community-dwelling older adults, gal-3 concentration was associated with central arterial stiffness, likely sharing common pathways with traditional cardiovascular risk factors.
Authors: Amil M Shah; Brian Claggett; Laura R Loehr; Patricia P Chang; Kunihiro Matsushita; Dalane Kitzman; Suma Konety; Anna Kucharska-Newton; Carla A Sueta; Thomas H Mosley; Jacqueline D Wright; Joseph Coresh; Gerardo Heiss; Aaron R Folsom; Scott D Solomon Journal: Circulation Date: 2016-11-23 Impact factor: 29.690
Authors: Laura R Loehr; Wayne D Rosamond; Patricia P Chang; Aaron R Folsom; Lloyd E Chambless Journal: Am J Cardiol Date: 2008-02-14 Impact factor: 2.778
Authors: Robert M Weisbrod; Tina Shiang; Leona Al Sayah; Jessica L Fry; Saumendra Bajpai; Cynthia A Reinhart-King; Heinrich E Lob; Lakshmi Santhanam; Gary Mitchell; Richard A Cohen; Francesca Seta Journal: Hypertension Date: 2013-09-23 Impact factor: 10.190
Authors: Wouter C Meijers; James L Januzzi; Christopher deFilippi; Aram S Adourian; Sanjiv J Shah; Dirk J van Veldhuisen; Rudolf A de Boer Journal: Am Heart J Date: 2014-03-05 Impact factor: 4.749
Authors: Laurent Calvier; Maria Miana; Pascal Reboul; Victoria Cachofeiro; Ernesto Martinez-Martinez; Rudolf A de Boer; Françoise Poirier; Patrick Lacolley; Faiez Zannad; Patrick Rossignol; Natalia López-Andrés Journal: Arterioscler Thromb Vasc Biol Date: 2012-11-01 Impact factor: 8.311
Authors: Oluwaseun E Fashanu; Faye L Norby; David Aguilar; Christie M Ballantyne; Ron C Hoogeveen; Lin Y Chen; Elsayed Z Soliman; Alvaro Alonso; Aaron R Folsom Journal: Am Heart J Date: 2017-07-08 Impact factor: 4.749